Aesara Europe Ltd 11542089 false 2023-01-01 2023-12-31 2023-12-31 The principal activity of the company is Pharmaceutical Consultants Digita Accounts Production Advanced 6.30.9574.0 true 11542089 2023-01-01 2023-12-31 11542089 2023-12-31 11542089 core:CurrentFinancialInstruments 2023-12-31 11542089 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 11542089 core:Non-currentFinancialInstruments core:AfterOneYear 2023-12-31 11542089 bus:SmallEntities 2023-01-01 2023-12-31 11542089 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 11542089 bus:AbridgedAccounts 2023-01-01 2023-12-31 11542089 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 11542089 bus:RegisteredOffice 2023-01-01 2023-12-31 11542089 bus:Director1 2023-01-01 2023-12-31 11542089 bus:Director2 2023-01-01 2023-12-31 11542089 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 11542089 bus:Agent1 2023-01-01 2023-12-31 11542089 countries:UnitedKingdom 2023-01-01 2023-12-31 11542089 2022-01-01 2022-12-31 11542089 2022-12-31 11542089 core:CurrentFinancialInstruments 2022-12-31 11542089 core:CurrentFinancialInstruments core:WithinOneYear 2022-12-31 11542089 core:Non-currentFinancialInstruments core:AfterOneYear 2022-12-31 iso4217:GBP xbrli:pure

Registration number: 11542089

Aesara Europe Ltd

Annual Report and Unaudited Abridged Financial Statements

for the Year Ended 31 December 2023

 

Aesara Europe Ltd

Contents

Company Information

1

Directors' Report

2

Abridged Balance Sheet

3 to 4

Notes to the Unaudited Abridged Financial Statements

5

 

Aesara Europe Ltd

Company Information

Directors

Gavin James Outteridge

Duyen Chinh Vu Pham

Registered office

41 Carden Road
Nunhead
London
SE15 3UB

Bankers

Barclays Bank Plc
188 Clapham High Street
Clapham Common
London
SW4 7UF

Accountants

Quartier Ltd
7 Becket Wood
Newdigate
Dorking
Surrey
RH5 5AQ

 

Aesara Europe Ltd

Directors' Report for the Year Ended 31 December 2023

The directors present their report and the abridged financial statements for the year ended 31 December 2023.

Directors of the company

The directors who held office during the year were as follows:

Gavin James Outteridge

Duyen Chinh Vu Pham

Principal activity

The principal activity of the company is Pharmaceutical Consultants

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 3 September 2024 and signed on its behalf by:
 

.........................................
Gavin James Outteridge
Director

 

Aesara Europe Ltd

(Registration number: 11542089)
Abridged Balance Sheet as at 31 December 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

5,824

3,177

Current assets

 

Debtors

276,573

166,611

Cash at bank and in hand

 

25,136

146,049

 

301,709

312,660

Prepayments and accrued income

 

15,226

6,867

Creditors: Amounts falling due within one year

(40,028)

(19,234)

Net current assets

 

276,907

300,293

Total assets less current liabilities

 

282,731

303,470

Creditors: Amounts falling due after more than one year

(941,581)

(346,300)

Accruals and deferred income

 

(5,019)

(45,849)

Net liabilities

 

(663,869)

(88,679)

Capital and reserves

 

Called up share capital

1

1

Retained earnings

(663,870)

(88,680)

Shareholders' deficit

 

(663,869)

(88,679)

For the financial year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 3 September 2024 and signed on its behalf by:
 

 

Aesara Europe Ltd

(Registration number: 11542089)
Abridged Balance Sheet as at 31 December 2023

.........................................
Gavin James Outteridge
Director

 

Aesara Europe Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 December 2023

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
41 Carden Road
Nunhead
London
SE15 3UB

These financial statements were authorised for issue by the Board on 3 September 2024.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2022 - 3).